Advent Life Sciences Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
112
- Portfolio
-
26
- Exits
-
48
Advent Life Sciences General Information
Company Description
Founded in 2005, Advent Life Sciences is a venture capital firm based in London, United Kingdom. The firm seeks to invest in life sciences businesses focusing on new drug discovery, small molecules, biologics, and new modalities, med tech, enabling technologies, and the vaccines sectors.
Business Details
Website
www.adventls.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 27 Fitzroy Square
- London W1T 6ES
- England, United Kingdom
Advent Life Sciences Investments (112)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| T-Therapeutics | 05-Nov-2026 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Glycomine | 14-May-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Artax Biopharma | 30-Apr-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Beacon Therapeutics | 09-Jan-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Cyted Health | 29-Aug-2025 | Diagnostic Equipment | Generating Revenue | |||
| Relief Cardiovascular | 26-Dec-2024 | Therapeutic Devices | Startup | |||
| Epitopea | 24-Oct-2024 | Drug Discovery | Generating Revenue | |||
| Nalu Medical | 09-Oct-2024 | Therapeutic Devices | Generating Revenue | |||
| AviadoBio | 08-Oct-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| F2G | 12-Sep-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Advent Life Sciences Exits (48)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Nalu Medical | 27-Jan-2026 | Merger/Acquisition | |
| Centessa Pharmaceuticals | 14-Nov-2025 | ||
| Alpha Anomeric | 29-Apr-2025 | ||
| MediGene | 16-Apr-2025 | ||
| MiroBio | 20-Sep-2022 | ||
| Aura Biosciences | 02-Nov-2021 | ||
| Centessa Pharmaceuticals | 28-May-2021 | ||
| Zikani Therapeutics | 01-Apr-2021 | ||
| Capella BioScience | 16-Feb-2021 | Merger/Acquisition | |
| Iterum Therapeutics | 26-Oct-2020 | Public Investment 2nd Offering |
Advent Life Sciences Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Advent Life Sciences Investments by Industry, Year, and Region
Advent Life Sciences Co-Investors (106)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| British Business Bank | 4 |
|
|
||
| F-Prime |
|
|
|||
| Gilde Healthcare |
|
|
|||
| Novo Holdings |
|
|
|||
| Forbion |
|
|
Advent Life Sciences FAQs
-
What is Advent Life Sciences?
Founded in 2005, Advent Life Sciences is a venture capital firm based in London, United Kingdom.
-
When was Advent Life Sciences founded?
Advent Life Sciences was founded in 2005.
-
Where is Advent Life Sciences headquartered?
Advent Life Sciences is headquartered in London, United Kingdom.
-
What is Advent Life Sciences's total asset value?
Advent Life Sciences has around in total assets under management.
-
How many investments has Advent Life Sciences made?
Advent Life Sciences has made 112 investments.
-
What has Advent Life Sciences invested in?
Advent Life Sciences has made numerous investments in companies like T-Therapeutics, Glycomine, and Artax Biopharma within the Drug Discovery industry.
-
What has Advent Life Sciences invested in recently?
Advent Life Sciences's latest investment was on 05-Nov-2026 in T-Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process